Antibiotic Resistance and Patient Safety: A Clinical Perspective
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Epidemiology & Public Health".
Deadline for manuscript submissions: 1 August 2026 | Viewed by 781
Special Issue Editors
2. Faculty of Science, Physical Education and Informatics, National University of Science and Technology, Politehnica, Splaiul Independenței 313, District 6, 060042 Bucharest, Romania
3. Emergency County Hospital of Pitești, Hospital Street No. 36, Pitești, Romania
Interests: nursing; public health; healthcare-associated infections; patient safety; anti-bioresistance
Special Issues, Collections and Topics in MDPI journals
2. Doctoral School, Carol Davila University of Medicine and Pharmacy, Eroii Sanitari 8, District 5, 050474 Bucharest, Romania
3. The Research Institute of the University of Bucharest—ICUB, Șoseaua Panduri 90, District 5, 050663 Bucharest, Romania
Interests: antimicrobial resistance; diagnostic microbiology; hospital-acquired infections; antibiotic stewardship; novel antimicrobial agents; microbiome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) represents one of the most serious threats to global health, undermining patient safety, clinical outcomes, and therapeutic effectiveness. Its emergence, rooted in an inevitable biological process accelerated by antibiotic misuse, has shifted research from classical microbiology to multidisciplinary and translational approaches addressing its growing complexity.
This Special Issue aims to examine the relationship between antibiotic resistance and patient safety from a clinical perspective, focusing on impacts on medical practice, infection prevention, and antimicrobial stewardship.
Recent advances include rapid detection of resistance genes through genomics, metagenomics, and AI-enhanced analytics; development of next-generation antimicrobials and alternative therapies (phages, peptides, and antibodies); CRISPR-based strategies; rapid diagnostics; biofilm-control innovations; and global surveillance systems that support optimized infection management.
We invite original research articles, reviews, and clinical studies. Contributions addressing, but not limited to, the following topics are encouraged:
- Emerging molecular mechanisms and evolutionary models of AMR;
- Clinical and epidemiological implications of multidrug-resistant organisms;
- Antimicrobial stewardship strategies in hospital and community settings;
- Impact of AMR on morbidity, mortality, and length of stay;
- Infection prevention and control protocols related to patient safety;
- Integration of rapid diagnostics and personalized approaches in clinical decision-making.
Prof. Dr. Monica Marilena Țânțu
Dr. Corneliu Ovidiu Vrancianu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- infection prevention
- multidrug-resistant infections
- patient safety
- antimicrobial stewardship
- multidrug-resistant organisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
